Litigation Details for ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD. (D.N.J. 2016)
✉ Email this page to a colleague
ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD. (D.N.J. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-12-07 |
Court | District Court, D. New Jersey | Date Terminated | 2018-10-09 |
Cause | 15:1126 Patent Infringement | Assigned To | John Michael Vazquez |
Jury Demand | None | Referred To | Mark Falk |
Parties | ABRAXIS BIOSCIENCE, LLC; CIPLA LTD. | ||
Patents | 6,096,331; 6,179,817; 6,197,051; 6,506,405; 6,537,579; 6,565,842; 6,749,868; 6,753,006; 7,820,788; 7,923,536; 8,138,229; 8,257,733; 8,268,348; 8,314,156; 8,853,260 | ||
Attorneys | CATHERINE THISBE MATTES; CHARLES MICHAEL LIZZA | ||
Firms | Kilpatrick Townsend & Stockton LLP; Quinn Emanuel Urquhart & Sullivan, LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD.
Biologic Drugs cited in ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for ABRAXIS BIOSCIENCE, LLC v. CIPLA LTD. (D.N.J. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2016-12-06 | 1 | This patent is subject to a terminal dis- 6,096,331 A 8/2000 …than about 1 micron. The use of speci?c 6,096,331. …2011/0118342 A1 5/2011 D6 6t 31. 6,096,331 A 8/2000 Desai et 3L …7,923,536 (the “’536 patent”), 8,138,229 (the “’229 patent”), and 8,853,260 (the “’260 patent”), all owned … 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |